AzTrials
AzTrials

BreastfeedingPUMMPPNCT06673160

Pumping to Up Maternal Milk Production for Preterms

A study testing Pumping every 2 hours and breast pumping every 3 hours in people with Breastfeeding and Breastmilk Expression, run by University of Alabama at Birmingham at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn about the effect of breast-pumping frequency on breast milk supply/ volume in mothers of preterm infants. The main question it aims to answer is: What effect does pumping frequency have on breast milk supply. Read more about this study

Who is it for?
Ages Up to 28 days
Conditions the study is for
Breastfeeding, Breastmilk Expression
What is being tested?
Pumping every 2 hours and breast pumping every 3 hours
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteUnited States
Study dates
11 Jun 2025to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 28 days
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Inborn infants <32 weeks gestation
  • Out-born infants transferred to our facility <48hours of life
  • Infants <1500 grams at birth
  • Infants whose parents/ guardians have provided legal consent for study participation

Who cannot join

  • Infants with birthing persons' that are severe/critically ill
  • Birthing persons of infants <18 years old
  • Infants with terminal illness or decision to withhold or limit support
  • infants with major congenital anomalies, chromosomal disorders, or congenital infections

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Colm Travers, MD contact

205-934-8793

cptravers@uabmc.edu

Folasade Aderibigbe, MD contact

205-934-8793

Sade.Aderibigbe72@gmail.com

United States1 site, 1 recruiting
  • University of Alabama Birmingham

    Birmingham, Alabama, 35249

    Colm Travers, MD, 205-934-4680, cptravers@uabmc.edu

    Folasade Aderibigbe, MD, 205-934-4680, fmaderibigbe@uabmc.edu

    Recruiting

Other trials in United States

About this study

Official title: Pumping to Up Maternal Milk Production for Preterms (PUMMPP)

The goal of this clinical trial is to learn about the effect of breast-pumping frequency on breast milk supply/ volume in mothers of preterm infants. The main question it aims to answer is:

  • What effect does pumping frequency have on breast milk supply.

Researchers will compare breastmilk supply of mothers who pump every 2 hours to the supply of those who pump every 3 hours to see if there is a difference in the amount of breastmilk they produce.

Participants will be assigned to either pump every 2 hours or every 3 hours and record how many milliliters of breastmilk they produce daily for the first 28 days of their baby's life.

Being tested
Pumping every 2 hours, breast pumping every 3 hours
Keywords
breastmilk supply in preterm infant, breastfeeding preterm infants
Medical subject headings
Breast Feeding, Breast Milk Expression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pumping every 2 hoursBehavioural

    Also called breast pumping every 2 hours

    The intervention will be pumping every 2 hours.

  • breast pumping every 3 hoursBehavioural

    The intervention will be pumping every 3 hours

Study groups in NCT06673160
Study groupRoleWhat they receive
Pumping every 2 hoursExperimentalMothers of patients in this group will be assigned to pump/ express breastmilk every 2 hours.
Receives: Behavioral: Pumping every 2 hours
Pumping every 3 hoursActive comparatorMothers of patients in this group will be assigned to pump/ express breastmilk every 3 hours.
Receives: Behavioral: breast pumping every 3 hours

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Volume of expressed breastmilk

    The primary outcome measure will be the volume of expressed breastmilk obtained in mL per day in the group pumping every 2 hours compared the group pumping every 3 hours

    Measured: From enrollment to 28 days of life

Secondary outcomes (12)
  1. The percentage of donor breast milk feedings

    This outcome will assess the percentage of any enteral feeding that is derived from donor breast milk.

    Measured: From enrollment to 28 days of life

  2. The number of days alive on full feedings

    The total number of days the infant received full enteral feeds (≥120 milliliters(mL)/kilogram(kg)/day).

    Measured: From enrollment to 28 days of life

  3. The time to full feedings

    The number of days it takes to initially reach full enteral feeds (≥120mL/kg/day)

    Measured: From enrollment to 28 days of life

  4. The number of infants with clinical evidence of feeding intolerance

    Infants that have enteral feeds withheld, or in other words made "nothing by mouth" (NPO) > 24 hours for feeding or abdominal issues

    Measured: From enrollment to first 28 days after birth

  5. Number of central line days

    The total number of days the infant maintained any type of central line access.

    Measured: In the first 28 days of life

  6. The number of infants receiving any volume of breastmilk at time of discharge

    Infants who are still receiving any volume of expressed breastmilk upon discharge will be identified and noted.

    Measured: From enrollment to hospital discharge

  7. The number of infants exclusively feeding breastmilk at discharge

    Whether or not enrolled infants are receiving all their nutrition from their mom's own expressed breastmilk upon discharge will be noted

    Measured: From enrollment to hospital discharge

  8. Average change in weight

    Changes in weight measured in grams (g) from birth to 36 weeks corrected gestational age

    Measured: from birth to 36 weeks' corrected gestational age

  9. Average change in length

    Changes in length measured in centimeters (cm)

    Measured: from birth to 36 weeks corrected gestational age

  10. Average change in head circumference

    Change in head circumference measured in centimeters (cm)

    Measured: from birth to 36 weeks' corrected gestational age

  11. The Bayley Scales of Infant and Toddler Development (BSID)

    The Bayley's cognitive component composite score will be assessed and noted.

    The cognitive composite score is determined by comparing the child's performance to a normative age-matched sample defined by the assessment. They are interpreted as follows:

    Mean score of 100 (Standard deviation=15) at the 50th percentile signifies mid-average functioning.

    Scores below 85 (1 Standard deviation below the mean), at the 16th percentile, indicate mild impairment of being 'at risk' of developmental delay. Monitoring is recommended, along with advice to parents on techniques to enhance development or referral to a therapist based on the level of impairment.

    Score below 70 (2 Standard deviation below the mean), at the second percentile, indicate moderate to severe impairment.

    In general, scores falling in the lowest 10th percentile indicate developmental delay.

    Measured: from 18-26 months of age

  12. The Bayley Scales of Infant and Toddler Development (BSID)

    The Bayley's motor component composite score will be assessed and noted.

    The motor composite score is determined by comparing the child's performance to a normative age-matched sample defined by the assessment. They are interpreted as follows:

    Mean score of 100 (Standard deviation=15) at the 50th percentile signifies mid-average functioning.

    Scores below 85 (1 Standard deviation below the mean), at the 16th percentile, indicate mild impairment of being 'at risk' of developmental delay. Monitoring is recommended, along with advice to parents on techniques to enhance development or referral to a therapist based on the level of impairment.

    Score below 70 (2 Standard deviation below the mean), at the second percentile, indicate moderate to severe impairment.

    In general, scores falling in the lowest 10th percentile indicate developmental delay.

    Measured: From 18-26 months of age

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Nov 2024
  2. Study start11 Jun 2025
  3. Primary completionSep 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06673160
Sponsor's protocol ID
IRB-300013718
Other IDs
UAB
Acronym
PUMMPP
Status last verified
Jul 2026
First submitted
23 Oct 2024
Last updated
16 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Travers CP, Carlo WA, McDonald SA, Das A, Ambalavanan N, Bell EF, Sanchez PJ, Stoll BJ, Wyckoff MH, Laptook AR, Van Meurs KP, Goldberg RN, D'Angio CT, Shankaran S, DeMauro SB, Walsh MC, Peralta-Carcelen M, Collins MV, Ball MB, Hale EC, Newman NS, Profit J, Gould JB, Lorch SA, Bann CM, Bidegain M, Higgins RD; Generic Database and Follow-up Subcommittees of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Racial/Ethnic Disparities Among Extremely Preterm Infants in the United States From 2002 to 2016. JAMA Netw Open. 2020 Jun 1;3(6):e206757. doi: 10.1001/jamanetworkopen.2020.6757.

    PubMed 32520359
  • Santoli CMA, Taylor-Cho IA, Darling AJ, Montoya MN, Gilner JB, Wheeler SM, Dotters-Katz SK. Predictors of Breastfeeding among Patients Admitted with Preterm Prelabor Rupture of Membranes. Am J Perinatol. 2024 May;41(S 01):e3196-e3201. doi: 10.1055/a-2211-1787. Epub 2023 Nov 15.

    PubMed 37967869
  • Quintero SM, Strassle PD, Londono Tobon A, Ponce S, Alhomsi A, Maldonado AI, Ko JS, Wilkerson MJ, Napoles AM. Race/ethnicity-specific associations between breastfeeding information source and breastfeeding rates among U.S. women. BMC Public Health. 2023 Mar 17;23(1):520. doi: 10.1186/s12889-023-15447-8.

    PubMed 36932332
  • Huang Y, Liu Y, Yu XY, Zeng TY. The rates and factors of perceived insufficient milk supply: A systematic review. Matern Child Nutr. 2022 Jan;18(1):e13255. doi: 10.1111/mcn.13255. Epub 2021 Aug 12.

    PubMed 34382733
  • Meek JY, Tippins S, American Academy of Pediatrics. American Academy of Pediatrics new mother's guide to breastfeeding. New York: Bantam Books; 2002. xiv, 258 p. p.

Questions about this trial

What is this clinical trial studying?

A study testing Pumping every 2 hours and breast pumping every 3 hours in people with Breastfeeding and Breastmilk Expression, run by University of Alabama at Birmingham at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Colm Travers, MD (205-934-8793, cptravers@uabmc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Volume of expressed breastmilk (time frame: From enrollment to 28 days of life). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06673160, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in